Inhibitory neurophysiological deficit as a phenotype for genetic investigation of schizophrenia

American Journal of Medical Genetics - Seminars in Medical Genetics

Volumn 97, Issue 1, 2000, Pages 58-64

  Freedman, Robert ^a   Adams, C E ^b   Adler, Lawrence E ^b   Bickford, Paula C ^b   Gault, Judith ^b   Harris, Josette G ^b   Nagamoto, Herbert T ^b   Olincy, Ann ^b   Ross, Randal G ^b   Stevens, Karen E ^b   Waldo, Merilyne ^b   Leonard, Sherry ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b NONE

Author keywords

Auditory evoked potential; Genetics; Inhibition; Nicotinic receptors; Schizophrenia

Indexed keywords

NICOTINIC RECEPTOR;

CHROMOSOME 15Q; EVOKED AUDITORY RESPONSE; GENE LOCUS; GENETIC LINKAGE; HEREDITY; HUMAN; INHERITANCE; NEUROBIOLOGY; NEUROPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; CHROMOSOME 15; GENETICS; METABOLISM; NERVOUS SYSTEM; PATHOPHYSIOLOGY;

CHROMOSOMES, HUMAN, PAIR 15; HUMANS; NERVOUS SYSTEM; PHENOTYPE; RECEPTORS, NICOTINIC; SCHIZOPHRENIA;

EID: 0034013468     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8628(200021)97:1<58::AID-AJMG8>3.0.CO;2-Y     Document Type: Review

References (71)

1. Adams CE, Stevens KE. 1998. Inhibition of nitric oxide synthetase disrupts inhibitory gating of auditory responses in rat hippocampus. J Pharmacol Exp Ther 287:760-765.
2. Adler LE, Pachtman E, Franks R, Pecevich M, Waldo MC, Freedman R. 1982. Neurophysiological evidence for a deficit in inhibitory mechanisms involved in sensory gating in schizophrenia. Biol Psychiatry 17: 639-654.
3. Adler LE, Gerhardt GA, Franks R, Baker N, Nagamoto H, Drebing C, Freedman R. 1989. Sensory physiology and catecholamines in schizophrenia and mania. Psychiatr Res 31:297-309.
4. Adler LE, Hoffer LJ, Griffith J, Waldo M, Freedman R. 1992. Normalization by nicotine of deficient auditory sensory gating in the relatives of schizophrenics. Biol Psychiatr 32: 607-616.
5. Adler LE, Hoffer LD, Wiser A, Freedman R. 1993. Normalization of auditory physiology by cigarette smoking in schizophrenic patients. Am J Psychiatr 150:1856-1861.
6. Andreasen NC, Paradiso S, O'Leary DS. 1998. "Cognitive dysmetria" as an integrative theory of schizophrenia: a dysfunction in cortical subcortical-cerebellar circuitry? Schizophr Bull 24:203-218.
7. Arolt V, Lencer R, Nolte A, Muller-Myhsok B, Purmann S, Schurmann M, Leutelt J, Pinnow M, Schwinger E. 1996. Eye tracking dysfunction is a putative phenotypic susceptibility marker of schizophrenia and maps to a locus on chromosome 6p in families with multiple occurrence of the disease. Am J Med Genet 67:564-579.
8. Baker NJ, Staunton M, Adler LE, Gerhardt GA, Drebing C, Waldo M, Nagamoto H, Freedman R. 1990. Sensory gating deficits in psychiatric inpatients: Relation to catecholamine metabolites in different diagnostic groups. Biol Psychiatr 27:519-528.
9. Berrettini WH, Ferraro TN, Goldin LR, Detera-Wadleigh SD, Choi H, Muniec D, Guroff JJ, Kazuba DM, Nurnberger JI Jr, Hsieh WT, Hoehe MR, Gershon ES. 1997. A linkage study of bipolar illness. Arch Gen Psychiatry 54:27-35.
10. Bickford PC, Luntz-Leybman V, Freedman R. 1993. Auditory sensory gating in the rat hippocampus: modulation by brainstem activity. Brain Res 607:33-38.
11. Bickford-Wimer PC, Nagamoto H, Johnson R, Adler LE, Egan M, Rose GM, Freedman R. 1990. Auditory sensory gating in hippocampal neurons: a model system in the rat. Biol Psychiatr 27:183-192.
12. Bickford PC, Wear KD. 1995. Restoration of sensory gating of auditory evoked response by nicotine in fimbria-fornix lesioned rats. Brain Res 705:235-240.
13. Blouin JL, Dombroski BA, Nath SK, Lasseter VK, Wolyniec PS, Nestadt G, Thornquist M, Ullrich G, Mcgrath J, Kasch L, Lamacz M, Thomas MG, Gehrig C, Radhakrishna U, Snyder SE, Balk KG, Neufeld K, Swartz KL, Demarchi N, Papadimitriou GN, Dikeos DG, Stefanis CN, Chakravarti A, Childs B, Housman DE, Pulver AE. 1998. Schizophrenia susceptibility loci on chromosome 13q31 and 8p21. Nature Genet 20: 70-73.
14. Borecki IB, Rao DC, Yaouanq J, Lalouel JM. 1990. Serum ferritin as a marker of affection for genetic hemochromatosis. Human Hered 40:159-166.
15. Boutros NN, Zouridakis G, Overall J. 1991. Replication and extension of P50 findings in schizophrenia. Clin Electroencephalogr 22:40-45.
16. 125I]-α-bungarotoxin binding in human postmortem brain. J Comp Neurol 387: 385-398.
17. Calzolari E, Aiello V, Pallazzi P, Sensi A, Calzolari S, Orrico D, Calliari L, Holler H, Marzi C, Belli S, Bernardi F, Patracchini P. 1996. Psychiatric disorder in a familial 15;18 translocation and sublocalization of myelin basic protein on 18q22.3. Am J Med Genet. 67:154-161.
18. Cannon TD, Zorilla LE, Shatself LE. 1994. Neuropsychological functioning in siblings discordant for schizophrenia and healthy volunteers. Arch Gen Psychiatry 51:651-661.
19. Cao Q, Martinez M, Zhang J, Sanders AR, Badner JA, Cravchik A, Markey C, Beshah E, Guroff JJ, Maxwell ME, Kazuba D, Goldin LR, Gerhson EV, Gejman, P. 1997. Suggestive evidence for a schizophrenia susceptibility locus on chromosome 6q and a confirmation in an independent series of pedigrees. Genomics 43:1-8.
20. Casaubon LK, Melanson M, Lopes-Cendes I, Marineau C, Andersmann E, Andersmann F, Weissenbach J, Prevost C, Bouchard JP, Mathieu J, Rouleau GA. 1996. The gene responsible for a severe form of peripheral neuropathy and agenesis of the corpus callosum maps to chromosome 15q. Am J Hum Genet 58:28-34.
21. Chini B, Raimond E, Elgoyhen AB, Moralli D, Balzaretti M, Heinemann S. 1994. Molecular cloning and chromosomal localization of human α7-nicotinic receptor subunit gene (CHRNA7). Genomics 19:379-381.
22. Clarke DJ. 1993. Prader-Willi syndrome and psychoses. Br J Psychiatry 163:680-684.
23. Clementz BA, Geyer MA, Braff DL. 1997. P50 suppression among the relatives of schizophrenia patients. Schizophr Res 24:232.
24. Clementz BA, Geyer MA, Braff DL. 1998. Multiple site evaluation of P50 suppression among schizophrenia and normal comparison subjects. Schizophr Res 30:71-80.
25. Coon H, Plaetke R, Holik J, Hoff M, Myles-Worsley M, Freedman R, Byerley W. 1993. Use of a neurophysiological trait in linkage analysis of schizophrenia. Biol Psychiatr 34:277-289.
26. Cornblatt BA, Keilp JG. 1994. Impaired attention, genetics, and the pathophysiology of schizophrenia. Schizophr Bull 20:31-46.
27. Cullum CM, Harris JG, Waldo MC, Smernoff E, Madison A, Nagamoto HT, Griffith J, Adler LE, Freedman R. 1993. Neurophysiological and neuropsychological evidence for attentional dysfunction in schizophrenia. Schizophr Res 10:131-141.
28. Curtis L, Blouin JL, Radhakrishna U, Gehrinf C, Lasseter VK, Wolyniec P, Dombroski B, Kazazian HH, Pulver AE, Housman D, Bertrand D, Antonarakis SE. 1999. No evidence of linkage between schizophrenia and markers at chromosome 15q13-14. Am J Med Genet 88:109-112.
29. de Amicis LA, Wagstaff DA, Cromwell RL. 1986. Reaction time crossover as a marker of schizophrenia and of higher functioning. J Nerv Ment Dis 174:177-179.
30. Edenberg HJ, Foroud T, Conneally PM, Sorbel JJ, Carr K, Crose C, Willig C, Zhao J, Miller M, Bowman E, Mayeda A, Rau NL, Smiley C, Rice JP, Goate A, Reich T, Stine OC, McMahon F, DePaulo JR, Meyers D, Detera-Wadleigh SD, Goldin LR, Gershon ES, Blehar MC, Nurnberger Jr JI. 1997. Initial genomic scan of the NIMH genetics initiative bipolar pedigrees: chromosomes 3, 5, 15, 16, 17, and 22. Am J Med Genet 74:238-246.
31. Erwin RJ, Mawhinney-Hee M, Gur RC, Gur RE. 1991. Mid-latency auditory evoked responses in schizophrenia. Biol Psychiatry 30:430-442.
32. Erwin RJ, Turetsky BJ, Moberg P, Gur RC, Gur RE. 1998. P50 abnormalities in schizophrenia: relationship to clinical and neurophysiological indices of attention. Schizophr Res 33:157-167.
33. Frazier CJ, Rollins YD, Breese CR, Leonard S, Freedman R, Dunwiddie TV. 1997. Acetylcholine activates an α-bungarotoxin sensitive nicotinic current in rat hippocampal interneurons, but not pyramidal cells. J Neurosci 18:1187-1195.
34. Freedman LR, Rock D, Roberts SA, Cornblatt BA, Erlenmeyer-Kimling L. 1998. The New York High-Risk Project: attention, anhedonia and social outcome. Schizophr Res 30:1-9.
35. Freedman R, Adler LE, Bickford P, Byerley W, Coon H, Cullum MC, Griffith JM, Harris JG, Leonard S, Miller C, Myles-Worsley M, Nagamoto HT, Rose GM, Waldo M. 1994. Schizophrenia and nicotinic receptors. Harvard Rev Psychiatry 2:179-192.
36. Freedman R, Coon H, Myles-Worsley M, OrrUrtreger A, Olincy A, Davis A, Polymeropoulos M, Holik J, Hopkins J, Hoff M, Rosenthal J, Waldo MC, Reimherr F, Wender P, Yaw J, Young DA, Breese CR, Adams C, Patterson D, Adler LE, Kruglyak L, Leonard S, Byerley W. 1997. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc Natl Acad Sci 94:587-592.
37. Freedman R, Wetmore C, Stromberg I, Leonard S, Olson L. 1993. a-Bungarotoxin binding to hippocampal interneurons: immunocytochemical characterization and effects on growth factor expression. J Neurosci 13: 1965-1975.
38. Gault J, Robinson M, Berger R, Drebing C, Logel J, Hopkins J, Moore T, Jacobs S, Merriwether J, Choi MJ, Kim EJ, Walton K, Buiting K, Davis A, Breese C, Freedman R, Leonard S. 1998. Genomic organization and partial duplication of the human α7 neuronal nicotinic acetylcholine receptor gene. Genomics 52:173-185.
39. Goldberg TE, Rigland JD, Torrey EF, Gold JM, Bigelow LB, Weinberger DR. 1990. Neuropsychological assessment of monozygotic twins discordant for schizophrenia. Arch Gen Psychiatry 47:1066-1072.
40. Griffith J, Hoffer LD, Adler LE, Zerbe GO, Freedman R. 1995. Effects of sound intensity on a mid-latency evoked response to repeated auditory stimuli in schizophrenic and normal subjects. Psychophysiology 32: 460-466.
41. Harris JG, Adler LE, Young DA, Cullum CM, Rilling LM, Cicerello A, Intemann PM, Freedman R. 1996. Neuropsychological dysfunction in parents of schizophrenics. Schizophr Res 20:253-260.
42. Hershman KM, Freedman R, Bickford PC. 1995. GABA-B antagonists diminish the inhibitory gating of auditory response in the rat hippocampus. Neurosci Lett 190:133-136.
43. Holzman PS, Kringlen E, Matthysse S, Flanagan SD, Lipton RB, Cramer G, Levin S, Lange K, Levy DL. 1988. A single dominant gene can account for eye tracking dysfunction and schizophrenia in offspring of discordant twins. Arch Psychiatry 45:641-647.
44. Jin Y, Potkin SG, Patterson JV, Sandman CA, Hetrick WP, Bunney Jr WE. 1997. Effects of P50 temporal variability on sensory gating in schizophrenia. Psychiatry Res 70:71-81.
45. Judd LL, McAdams L, Budnick B, Braff DL. 1992. Sensory gating deficit in schizophrenia: new results. Am J Psychiatry 149:488-493.
46. Kaufmann CA, Suarez B, Malaspina D, Pepple J, Svrakic D, Markel PD, Meyer J, Zambuto CT, Schmitt K, Matise TC, Friedman JMH, Hampe C, Lee H, Shore D, Wynne D, Faraone SV, Tsuang MT, Cloninger CR. 1998. NIMH Genetics Initiative Millenium Consortium - linkage analysis of African-American pedigrees. Am J Med Genet 81:282-289.
47. Leonard S, Gault J, Moore T, Hopkins J, Robinson M, Olincy A, Adler LE, Cloninger R, Kaufmann CA, Tsuang MT, Faraone SV, Malaspina D, Svrakic DM, Freedman R. 1998. Further Investigation of a chromosome 15 locus in schizophrenia: analysis of affected sib pairs from the NIMH Genetics Initiative. Neuropsychiatr Genet 81:308-312.
48. Leppert M, Burt R, Hughes JP, Samonitz W, Nakamura Y, Woodward S, Gardner E, Lalouel JM, White R. 1990. Genetic analysis of an inherited predisposition to colon cancer in a family with a variable number of adenomatous polyps. N Engl J Med 322: 904-908.
49. Luntz-Leybman V, Bickford PC, Freedman R. 1992. Cholinergic gating of response to auditory stimuli in rat hippocampus. Brain Res 587:130-136.
50. McKenna K, Gordon CT, Rapoport JL. 1994. Childhood onset schizophrenia: timely neurobiological research. J Am Acad Child Adol Psychiatr 33:771-781.
51. Miller CL, Freedman R. 1993. Medial septal neuron activity in relation to an auditory sensory gating paradigm. Neuroscience 55: 373-380.
52. Miller CC, Freedman R. 1995. The activity of hippocampal interneurons and pyramidal cells during the response of the hippocampus to repeated auditory stimuli. Neuroscience 69:371-381.
53. Nagamoto HT, Adler LE, Waldo MC, Freedman R. 1989. Sensory gating in schizophrenics and normal controls: effects of changing stimulation interval. Biol Psychiatry 25:549-561.
54. Nelson MD, Saykin AJ, Flashman LA, Riordan HJ. 1998. Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging: a meta-analytic study. Arch Gen Psychiatry 55:433-440.
55. Neves-Pereira M, Braganza-King N, Walker ML, Kennedy JL. 1999. TDT studies of CHRNA7 in schizophrenia and bipolar disorder. Schizophr Res 30:93.
56. Neves-Pereira M, Bassett AS, Honer WG, Lang D, King NA, Kennedy JL. 1998. No evidence for linkage of the CHRNA7 gene region in Canadian schizophrenia families. Am J Med Genet 81:361-363.
57. Olincy A, Ross RG, Young DA, Roath M, Freedman R. 1998. Improvement in smooth pursuit eye movements after cigarette smoking in schizophrenic patients. Neuropsychopharmacology 18:175-185.
58. Olincy A, Young DA, Freedman R. 1997. Increased levels of nicotine metabolite cotinine in schizophrenic smokers compared to other smokers. Biol Psychiatry 42:1-5.
59. Ross RG, Harris JG, Olincy A, Radant A, Adler LE, Freedman R. 1998. Anticipatory saccades during smooth pursuit eye movements and familial transmission of schizophrenia. Biol Psychiatry 8:690-697.
60. Ross RG, Olincy A, Harris JG, Radant A, Hawkins M, Adler LE, Freedman R. 1999. Evidence for bilineal inheritance of physiological indicators of risk in childhood-onset schizophrenia. Am J Med Genet Neuropsychiatric Genet 88:188-199.
61. Rutter M, Silberg J, O'Connor T, Simonoff E. 1999. Genetics and child psychiatry: II Empirical research findings. J Child Psychol Psychiatry 40:19-55.
62. Sham PC, Morton NE, Muir WJ, Walker M, Collins A, Shields DC, St Clair DM, Blackwood DH. 1994. Segregation analysis of complex phenotypes: an application to schizophrenia and auditory P300 latency. Psychiatr Genet 4:29-38.
63. Shihabuddin L, Silverman JM, Buchsbaum MS, Seiver LJ, Luu C, Germans MK, Metzger M, Mohs RC, Smith CJ, Spiegel-Cohen J, Davis KL. 1996. Ventricular enlargement associated with linkage marker for schizophrenia-related disorders in one pedigree. Mol Psychiatry 1:215-222.
64. Sirota P, Frydman M, Sirota L. 1990. Schizophrenia and Marfan syndrome. Br J Psychiatry 157:433-436.
65. Stevens KE, Freedman R, Collins AC, Hall M, Leonard S, Marks MJ, Rose GM. 1996. Genetic correlation of inhibitory gating of hippocampal auditory evoked response and alpha-bungarotoxin-binding nicotinic cholinergic receptors in inbred mouse strains. Neuropsychopharmacology 15: 152-162.
66. Tamminga CA, Thaker GK, Buchanan R, Kirkpatrick B, Alphs LD, Chase TN, Carpenter WT. 1992. Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome. Arch Gen Psychiatry 49:522-530.
67. Tsuang MT, Lyons MJ, Faraone SV. 1990. Heterogeneity of schizophrenia: conceptual models and analytic strategies. Br J Psychiatry 156:17-26.
68. Waldo MC, Cawthra E, Adler LE, Dubester S, Staunton M, Nagamoto H, Baker N, Madison A, Simon J, Scherzinger A, Drebing C, Gerhardt G, Freedman R. 1994. Auditory sensory gating, hippocampal volume, and catecholamine metabolism in schizophrenics and their siblings. Schizophr Res 12:93-106.
69. Waldo M, Myles-Worsley M, Madison A, Byerley W, Freedman R. 1995. Sensory gating deficits in parents of schizophrenics. Am J Med Genet 60:506-511.
70. Ward PB, Hoffer LD, Liebert BJ, Catts SV, O'Donnell M, Adler LE. 1996. Replication of a P50 auditory gating deficit in Australian patients with schizophrenia. Psychiatry Res 64:121-135.
71. Yee CM, Neuchterlain KH, Morris SE, White PM. 1998. P50 suppression in recent-onset schizophrenics: clinical correlates and risperidone effect. J Abnorm Psych 107:691-698.